Axon Drugs Private Limited, a active private limited company, was established on 10 July 1990 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24117TN1990PTC019380. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
Formerly known as Alsalabs Pvt Ltd. It upholds a compliant status. Employing 53 professional, Its leadership includes Pushpakala Harirajan (Whole-Time Director), Vikram Harirajan (Director), Damodaram Harirajan (Managing Director). Past directors included Shanthamohan Anbil Rajmohan, Mittalal Surajmal, Pushpakala Harirajan. It holds ₹14.21 Cr open charges and ₹5.69 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.14, Santhosh Nagar, Korattur North, Chennai, Tamil Nadu, 600076.
U24117TN1990PTC019380
019380
10 July 1990
₹2.00 Cr
₹2.00 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Axon Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pushpakala Harirajan | Whole-Time Director | 10 Jul 1990 | Current |
| Vikram Harirajan | Director | 14 Aug 2008 | Current |
| Damodaram Harirajan | Managing Director | 10 Jul 1990 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Aug 2008 | Past |
| Pramod Abcsdd | Director | 18 Jul 2020 | Past |
| Pramod Abcsdd | Director | 31 Mar 2023 | Past |
| Pramod Abcsdd | Director | 31 Mar 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Axon Drugs Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 3.71% increase. The company also saw a substantial improvement in profitability, with a 91.12% increase in profit. The company's net worth Soared by an impressive increase of 16.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Axon Drugs had a public holding of 8.51%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹142,145,000.00
₹5,688,800.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jul 2013 | Indian Overseas Bank | ₹10.00 Cr | Open |
| 28 Feb 2000 | Indian Overseas Bank | ₹4.30 M | Open |
| 07 Oct 1999 | Indian Overseas Bank | ₹0.40 M | Open |
| 21 Mar 1997 | Indian Overseas Bank | ₹0.50 M | Open |
| 24 Jul 1992 | Indian Overaseas Bank | ₹0.70 M | Open |
Explore comprehensive loan charge details -
Axon Drugs has a workforce of 53 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Axon Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axon Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Axon Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Axon Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
Progress on A charge with Indian Overseas Bank of Rs. 3.57 Cr registered on 18 Jul 1992 with Charge ID 90290048 was modified on 12 Jan 2024. was documented.
Progress on A charge with Indian Overseas Bank amounted to Rs. 10.00 Cr with Charge ID 10439382 was registered on 22 Jul 2013. was documented.
Progress on Vikram Harirajan was appointed as a Director was appointed as a Director on 14 Aug 2008 & has been associated with this company since 17 years 3 months . was documented.
The activity A charge registered on 26 Jul 2002 via Charge ID 90301095 with Tamil Nadu Industrial Investment Corporation Limited was fully satisfied on 28 Aug 2007. was completed.
The CIN of Axon Drugs Private Limited is U24117TN1990PTC019380.
Axon Drugs Private Limited is headquartered at Plot No.14, Santhosh Nagar, Korattur North, Chennai, Tamil Nadu, 600076.
Axon Drugs Private Limited was incorporated on 10 July 1990.
The current directors of Axon Drugs Private Limited are
The primary industry of Axon Drugs Private Limited is Manufacturing.
Axon Drugs Private Limited is unlisted.
The authorized capital of Axon Drugs Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Axon Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX